Novel water-soluble and pH-responsive anticancer drug nanocarriers: Doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs)

被引:93
作者
Chang, Yulei [1 ]
Meng, Xinlei [1 ]
Zhao, Yili [1 ]
Li, Kun [1 ]
Zhao, Bao [1 ]
Zhu, Ming [1 ]
Li, Yapeng [1 ]
Chen, Xuesi [2 ]
Wang, Jingyuan [1 ]
机构
[1] Jilin Univ, Dept Chem, Alan G MacDiarmid Inst, Changchun 130023, Peoples R China
[2] Chinese Acad Sci, Chang Chun Inst Appl Chem, Changchun 130022, Peoples R China
关键词
Dendrimers; PAMAM; Doxorubicin; DOX; Iron oxide NPs; RESONANCE CONTRAST AGENTS; TUMOR; MICELLES; DELIVERY;
D O I
10.1016/j.jcis.2011.06.086
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070305 [高分子化学与物理];
摘要
PH-responsive drug release system based on the conjugates of PAMAM dendrimers-doxorubicin (PAMAM-DOX) and superparamagnetic iron oxide (Fe3O4) nanoparticles (IONPs) has been constructed and characterized. The IONPs were stabilized by mPEG-G2.5 PAMAM dendrimers. The anticancer drug DOX was conjugated to the dendrimer segments of amino-stabilized IONPs using hydrazine as the linker via hydrazone bonds, which is acid cleavable and can be used as an ideal pH-responsive drug release system. The drug release profiles of DOX-PAMAM dendrimer conjugates were studied at pH 5.0 and 7.4. The results showed that the hydrolytic release profile can be obtained only at the condition of lysosomal pH (pH = 5.0), and IONPs participated in carrying DOX to the tumor by the Enhanced Permeability and Retention (EPR) effect. These novel DOX-conjugated IONPs have the potential to enhance the effect of MRI contrast and cancer therapy in the course of delivering anticancer drugs to their target sites. Although the dendrimer-DOX-coated IONPs do not have any targeting ligands attached on their surface, they are potentially useful for cancer diagnosis in vivo. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 31 条
[1]
Dendrisomes: cationic lipidic dendron vesicular assemblies [J].
Al-Jamal, KT ;
Sakthivel, T ;
Florence, AT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 254 (01) :33-36
[2]
Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers [J].
Aryal, Santosh ;
Grailer, Jamison J. ;
Pilla, Srikanth ;
Steeber, Douglas A. ;
Gong, Shaoqin .
JOURNAL OF MATERIALS CHEMISTRY, 2009, 19 (42) :7879-7884
[3]
Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: Pluronic P85 [J].
Batrakova, Elena V. ;
Kelly, David L. ;
Li, Shu ;
Li, Yili ;
Yang, Zhihui ;
Xiao, Li ;
Alakhova, Daria Y. ;
Sherman, Simon ;
Alakhov, Valery Yu. ;
Kabanov, Alexander V. .
MOLECULAR PHARMACEUTICS, 2006, 3 (02) :113-123
[4]
Dendritic magnetite nanocarriers for drug delivery applications [J].
Chandra, Sudeshna ;
Mehta, Shailee ;
Nigam, Saumya ;
Bahadur, D. .
NEW JOURNAL OF CHEMISTRY, 2010, 34 (04) :648-655
[5]
Multifunctional Magnetoplasmonic Nanoparticle Assemblies for Cancer Therapy and Diagnostics (Theranostics) [J].
Chen, Wei ;
Xu, Naifeng ;
Xu, Liguang ;
Wang, Libing ;
Li, Zuokun ;
Ma, Wei ;
Zhu, Yingyue ;
Xu, Chuanlai ;
Kotov, Nicholas A. .
MACROMOLECULAR RAPID COMMUNICATIONS, 2010, 31 (02) :228-236
[6]
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting [J].
Chytil, P. ;
Etrych, T. ;
Konak, C. ;
Sirova, M. ;
Mrkvan, T. ;
Boucek, J. ;
Rihova, B. ;
Ulbrich, K. .
JOURNAL OF CONTROLLED RELEASE, 2008, 127 (02) :121-130
[7]
Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation:: Effect of polymer chain modification [J].
Chytil, Petr ;
Etrych, Tomas ;
Konak, Cestmir ;
Sirova, Milada ;
Mrkvan, Tomas ;
Rihova, Blanka ;
Ulbrich, Karel .
JOURNAL OF CONTROLLED RELEASE, 2006, 115 (01) :26-36
[8]
New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage:: synthesis and preliminary in vitro and in vivo biological properties [J].
Etrych, T ;
Jelínková, M ;
Ríhová, B ;
Ulbrich, K .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (01) :89-102
[9]
STRUCTURAL COMPARISON OF ANTICANCER DRUG DNA COMPLEXES - ADRIAMYCIN AND DAUNOMYCIN [J].
FREDERICK, CA ;
WILLIAMS, LD ;
UGHETTO, G ;
VANDERMAREL, GA ;
VANBOOM, JH ;
RICH, A ;
WANG, AHJ .
BIOCHEMISTRY, 1990, 29 (10) :2538-2549
[10]
Gao X., 2004, NAT BIOTECHNOL, V22, P1